What is the Nurse Residency Program Data Telling You?

March 23, 2023

In this activity we will review the benchmarking report first, highlighting trends and best practices that are related to retention and satisfaction of new graduate nurses. Following the benchmarking report review, we will lead coordinators through their site reports, highlighting the data in each section, why it is important, and what it conveys about the organization. Lastly, we will review evaluation tools on the website that coordinators can use to report on their programs to leaders in the organization.

Target Audience

Nurses

Learning Objectives

At the conclusion of this activity, participants should be able to:

  1. Discuss trends in national data impacting residency retention rates in the Vizient/AACN Nurse Residency ProgramTM
  2. Identify hiring and termination trends in coordinators’ annual site report.
  3. Explain how to use the report to look at survey results and trend them over time.

Additional Information

AttachmentSize
PDF icon Helpful Tips for Users - Vizient CE System.pdf134.81 KB
File Mar 2023 What is the nurse residency program data telling you - CE Information for Credit - Live.docx120.98 KB
Course summary
Available credit: 
  • 1.00 ANCC
  • 1.00 CBRN
  • 1.00 General CE – Attendance
Course opens: 
03/23/2023
Course expires: 
05/07/2023
Event starts: 
03/23/2023 - 12:00pm CDT
Event ends: 
03/23/2023 - 1:00pm CDT
Add to calendar: 
Live
United States

Faculty

Angela Renkema, MPH, BSN, RN, NPD-BC, CV-BC, CPH
Director, Programmatic Advisory Services
Vizient, Inc.

 

Planning committee

Meg Ingram, MSN, RN
Sr Programmatic Advisor
Vizient, Inc.

Angela Renkema, MPH, BSN, RN, NPD-BC, CV-BC, CPH
Director, Programmatic Advisory Services
Vizient, Inc.

Dana Garcher, MS, RN
Sr. Programmatic Advisor
Vizient, Inc.

Vickie Adams, MSN, RN, NPD-BC
Sr. Programmatic Advisor
Vizient, Inc.

Lindsay Ross, MSN, RN, NPD-BC, CMSRN
Sr. Programmatic Advisor
Vizient, Inc.

Kaile Crawford, MSN, RN, NPD-BC
Sr. Programmatic Advisor
Vizient, Inc.
 

Disclosure of Financial Relationships:

Absence of Relevant Financial Relationships

Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.

No one in a position to control the content of this educational activity have relevant financial relationships with ineligible companies.

All others in a position to control content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

 

Statement of content validity

Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.

 

FDA off-label/unapproved usage

Faculty/Presenters are required to identify any new and evolving topics for which there is a lower/absence of evidence base. This is to ensure that our content does not advocate for, or promote, practices that are not, or not yet adequately based on current science, evidence, and clinical reasoning. Faculty/Presenters are required to disclose any discussion of (1) off-label/unapproved or investigational uses of FDA approved commercial products or devices and/or (2) products or devices not yet approved in the United States.

Disclaimer: The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Designation Statement(s):

NURSING

This activity is designated for 1.00 contact hours.

Vizient, Inc. is approved by the California Board of Registered Nursing, Provider Number CEP12580, for 1.00 contact hours.

 

OTHER

Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation indicating the maximum credits available. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.

Available Credit

  • 1.00 ANCC
  • 1.00 CBRN
  • 1.00 General CE – Attendance
Please login or register to take this course.